Cellibre, Inc.
Cellibre, Inc. uses biology as a manufacturing technology, leveraging nature to create sustainable products through strain engineering, biochemistry, and precision fermentation.
Funding history
About Cellibre, Inc.
How much funding has Cellibre, Inc. raised?
Cellibre, Inc. has raised $6.7M in total funding. The most recent round was Series A.
Where is Cellibre, Inc. headquartered?
Cellibre, Inc. is headquartered in San Diego, CA.
What does Cellibre, Inc. do?
Cellibre, Inc. uses biology as a manufacturing technology, leveraging nature to create sustainable products through strain engineering, biochemistry, and precision fermentation.
What problem does Cellibre, Inc. solve?
Traditional, farm- and smokestack-based manufacturing of products is not sustainable for the planet.
What's Cellibre, Inc.'s solution?
Cellibre uses synthetic biology -- strain engineering, biochemistry, and precision fermentation -- to design microbes that manufacture products, shifting production 'from the farm to fermentation.'
What makes Cellibre, Inc. different?
The page points to an integrated 'Bootup Biology' approach spanning strain engineering, protein/biochemistry optimization, and precision fermentation, and cites industry validation including an investment from Symrise and recognition as a winner of Ajinomoto's Next Generation of Taste and Texture Technologies (NGT3) competition.
What makes Cellibre, Inc. notable?
Cellibre, a San Diego biotech founded by CEO Ben Chiarelli in 2019, closed an $11.5M Series A led by Merida Capital Holdings to commercialize lab-cultured (fermentation-based) cannabinoids.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
